TrialNCT06959511
Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
- Status
- RECRUITING
- Phase
- PHASE2
- Last update posted
- 09/04/2026
- Start
- 07/22/2025
- Sponsor
- M.D. Anderson Cancer Center
- Specialties
- otolaryngology, oncology
Conditions: Neoadjuvant Treatment; Thyroid Cancer
Brief summary
To look at the effectiveness of zanzalintinib, followed by surgery, in treating advanced thyroid cancer. The safety of this treatment will also be studied.
Protocol documents and results are not hosted here. Verify every detail on ClinicalTrials.gov.